Pyrido[3,4-d]pyrimidine-2,4(1H,3H)-dione, 95.0%, 10g

N-methyl-3-(1-methyl-1H-imidazol-2-yl)-1-propanamine dihydrochloride, 95.0%, 1g

2-BROMO-4-METHYLPHENYLBORONIC ACID, 95%, 5g

6-Morpholinopyridin-3-ylboronic acid pinacol ester, 95.0%, 25g

(S)-Ethyl 2-hydroxy-4-phenylbutanoate, 95.0%, 10g

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-b]pyridazine, 98%, 1g

6-Nitroimidazo[1,2-a]pyridine, 97.0%, 25g

3-(4,4,4-trifluoro-3-hydroxybut-2-enoyl)benzonitrile, 95%, 250mg

7-Methylpyrazolo[1,5-a]pyridine-3-carboxylic acid, 95.0%, 250mg

1-Bromo-4-ethoxy-2-fluorobenzene, 95.0%, 5g

N-(2,2-Dimethoxyethyl)methacrylamide, 95+%, 5g

Recipiente de cristalización DURAN® sin pico, 900 ml, 140 mm, 1 Pieza

1-(4-Methoxy-benzyl)-piperidin-4-ylamine hydrochloride, 95.0%, 250mg